Passionflower for Health & Longevity - Quick Reference Sheet

Passionflower for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

A single dose before a stressful event calms about as much as a standard sedative drug, while leaving coordination, reaction speed and memory of the event intact. Measured sleep lengthens modestly. Benefit for long-standing anxiety is unsettled. It adds to anything else that sedates, and most tested supplements did not contain what their labels claimed. (Full Review)

Protocol

Standard European dry-extract protocol
200–800 mg dry extract daily
Or 0.5–2 g dried herb infused as tea up to three times daily. Most practitioners start at 250–400 mg.
Situational single-dose protocol
260–500 mg single dose
Taken 30–90 minutes before an anticipated stressor; the regimen used in surgical and dental trials.
Best time of day
Evening
Evening for the sleep and daily-calm goal, 30–90 minutes before the event for the situational goal. Daytime dosing is where sedation complaints concentrate.
Time to effect
Situational anxiety
30–90 minutes
Response to a single dose.
Sleep and daily calm
1–2 weeks
30-day trials showed further gain.
Minimum useful trial period
2 weeks
Set by the one-to-two-week window in which sleep and daily-calm effects were measured.

Benefits

Contraindications
  • Pregnancy at any gestational age, and breastfeeding
  • Congenital long-QT syndrome, QTc above 470 ms, or history of ventricular arrhythmia
  • Monoamine oxidase inhibitor use
  • Untreated moderate-to-severe obstructive sleep apnea (apnea-hypopnea index above 15 events per hour)
  • Decompensated liver disease (Child-Pugh Class C)
  • Prior hypersensitivity to Passiflora species or other Passifloraceae
  • Within 48 hours of driving-critical or safety-critical duty without a prior personal response test
Key Interactions
  • Benzodiazepines and Z-drugs: diazepam, alprazolam, lorazepam, oxazepam, zolpidem, zaleplon, eszopiclone
  • Opioids: oxycodone, morphine, tramadol, buprenorphine
  • General anesthetics and pre-medication
  • Sedating over-the-counter medicines: diphenhydramine, doxylamine, chlorpheniramine, "PM" analgesic combinations
  • Alcohol
  • Warfarin and antiplatelet agents
  • CYP3A4 substrates: simvastatin, atorvastatin, tacrolimus, ciclosporin, apixaban
  • Sedative supplements: valerian, kava, hops, lemon balm, chamomile, melatonin, magnesium glycinate, L-Theanine, cannabidiol
  • Antihypertensives and blood-pressure-lowering supplements

Risk & Side Effects

  • High: Drowsiness and daytime sedation
  • Medium: Potentiation of sedative and anti-anxiety drugs; substandard, misidentified or adulterated products
  • Low: Nausea, vomiting and dizziness at labeled doses; QT prolongation and non-sustained ventricular tachycardia; hypersensitivity vasculitis; adverse outcomes in pregnancy
  • Speculative: Reduced blood levels of CYP3A4-metabolized drugs

Monitoring

Marker Target Why
QTc interval Under 430 ms (men), under 440 ms (women) Screens the one serious cardiac signal reported
Serum potassium 4.2–4.6 mmol/L Low potassium lengthens repolarization independently
Serum magnesium (red blood cell) 5.0–6.5 mg/dL Low magnesium compounds any repolarization effect
ALT 10–26 U/L (men), 10–19 U/L (women) Confirms no unexpected liver effect from a multi-herb product
Insomnia Severity Index Under 8 The primary success measure for the sleep goal
GAD-7 anxiety score 4 or below The primary success measure for the anxiety goal
Sleep efficiency 88–92% Tracks the objective sleep endpoint that moved in trial

Cadence: Symptom scores at 2 weeks and 4 weeks, then every 3 months while use continues. Electrocardiogram repeated only if the dose rises or a QT-prolonging drug is added; liver enzymes rechecked annually.

Qualitative Assessment

  • Morning grogginess in the first hour after waking — the earliest sign the dose is too high or too late
  • Daytime alertness and reaction quality, particularly during driving or training
  • Ease of falling asleep, as distinct from total sleep time
  • Subjective evenness of mood under a known stressor, rather than at rest
  • Absence of memory gaps around the evening dose